Aarti Pharmalabs Limited (BOM:543748)

Market Cap	64.07B -5.2%
Revenue (ttm)	18.01B -12.5%
Net Income	2.14B -14.3%
EPS	23.56 -14.3%
Shares Out	n/a
PE Ratio	29.97
Forward PE	n/a
Dividend	4.00 (0.57%)
Ex-Dividend Date	Feb 16, 2026

Volume	7,213
Average Volume	9,713
Open	678.00
Previous Close	676.10
Day's Range	669.55 - 709.90
52-Week Range	583.85 - 971.50
Beta	n/a
RSI	50.58
Earnings Date	May 8, 2026

About Aarti Pharmalabs

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides con...

• Industry: Pharmaceutical Preparations
• Founded: 2019
• Employees: 2,162
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543748

Financial Performance

In fiscal year 2025, Aarti Pharmalabs's revenue was 21.15 billion, an increase of 14.17% compared to the previous year's 18.53 billion. Earnings were 2.72 billion, an increase of 25.59%.